Labcorp EVP Brian Caveney sells $494,000 in common stock

Published 05/06/2025, 13:24
Labcorp EVP Brian Caveney sells $494,000 in common stock

In recent trading activity, Brian J. Caveney, the Executive Vice President and President of Enterprise Diagnostics, Chief Medical (TASE:BLWV) Officer, and Chief Scientific Officer at Labcorp Holdings Inc. (NYSE:LH), sold 2,000 shares of the company’s common stock. The $21.3 billion healthcare diagnostics company has shown strong momentum, with the stock trading near its 52-week high and demonstrating low price volatility, according to InvestingPro data. The shares were sold at a price of $247.00 each, totaling approximately $494,000. Following this transaction, Caveney holds 30,066.6573 shares directly. While this insider sale occurred, InvestingPro analysis reveals management has been actively buying back shares, and 7 analysts have recently revised their earnings expectations upward. For deeper insights into Labcorp’s valuation and growth prospects, including exclusive ProTips and comprehensive financial analysis, explore the full Pro Research Report available on InvestingPro.

In other recent news, LabCorp reported its Q1 2025 earnings, revealing a revenue increase to $3.3 billion, up 5.3% year-over-year, although this figure fell short of the anticipated $3.41 billion. The company achieved an adjusted earnings per share (EPS) of $3.84, slightly surpassing the expected $3.78. Meanwhile, LabCorp’s shareholders approved new incentive plans during the company’s Annual Meeting. These include the 2025 Omnibus Incentive Plan and the 2025 Employee Stock Purchase Plan, aligning employee and shareholder interests. Additionally, Mizuho (NYSE:MFG) Securities maintained its Outperform rating on LabCorp, raising the stock target to $274. This adjustment reflects confidence in the company’s earnings visibility despite economic challenges. LabCorp also announced new product launches, including LabCorp Plasma Complete and genetic risk panel tests, as part of its strategic focus on high-growth areas. Lastly, the company is targeting $100-$125 million in cost savings through its Launchpad initiative.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.